secwatch.observer — SEC 8-K summary
======================================

Issuer:     BiomX Inc. (PHGE)
CIK:        0001739174
Form:       8-K
Filed at:   2026-08-25T21:00:14+00:00
Accession:  0001213900-26-093565
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BiomX shareholders approve Dr. Frucht issuance, reverse split, auditor ratification
--------------------------------------------------------------------------------

- Approved issuance of shares to Mandragola Ltd. for Dr. Frucht Systems acquisition: 9,313,228 for, 429,645 against.
- Approved reverse stock split of 1-for-5 to 1-for-20; authorized shares cut from 750M to 150M.
- Ratified Barzily & Co. as independent auditor for FY2026: 9,575,900 for.
- Quorum reached with 9,813,430 shares (36.9% of 26,559,607 outstanding); adjournment not needed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739174/000121390026093565/0001213900-26-093565-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739174/000121390026093565/ea0303308-8k_biomx.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-093565

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer